In our study, AZD8055, an mTOR inhibitor, significantly decreased the phosphorylation of S6K, resulting in repression of the expression of Mcl-1 in the two pancreatic cancer cell lines. The gene discussed is RPS6KB1; the disease is pancreatic neoplasm.